Nimbus Therapeutics
Cambridge, United States· Est.
Nimbus Therapeutics designs small molecule medicines for challenging targets in oncology, immunology, and metabolic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $335M
About
Nimbus Therapeutics designs small molecule medicines for challenging targets in oncology, immunology, and metabolic diseases.
OncologyImmunologyMetabolic
Funding History
2Total raised:$335M
Venture$210M
Venture$125M